Anne-Lise M.
- Country
- France
- Department
- Service d'Hématologie
Research Overview
- Phase 3 Randomized Open-Label Study of Axatilimab Versus Best Available Therapy in Chronic Graft-Versus-Host Disease Post Two Systemic Therapy Lines
- Evaluation of Allogeneic Fecal Microbiota Transplantation for Complication Prevention Post-Allogeneic Hematopoietic Stem Cell Transplantation in Hematologic Malignancies
Data & Insights
Has run more than one trial at 10 of 116 partner sites.
Specializations
Hematologic Transplantation
This investigator specializes in allogeneic hematopoietic stem cell transplantation (allo-HSCT), with particular emphasis on treating various hematological malignancies. Their research extends to managing transplant-related complications and optimizing patient outcomes.
- Graft-versus-host disease prevention
- Post-transplant survival optimization
- Myeloablative conditioning protocols
The investigator explores innovative approaches including fecal microbiota transplantation as a preventive strategy for post-transplant complications.
Blood Disorders Management
Their expertise includes treating pure red cell aplasia (PRCA) that occurs following major ABO mismatched transplants. The investigator studies advanced therapeutic interventions using targeted immunotherapy approaches.
- ABO mismatch complications
- Monoclonal antibody therapy
- Post-transplant recovery
Research focuses on evaluating anti-CD38 monoclonal antibody treatments for post-transplant complications.
Therapeutic Innovation
The investigator develops novel therapeutic strategies for hematological disorder management, combining conventional transplantation approaches with emerging immunological treatments.
- Supportive care optimization
- Treatment protocol development
- Clinical outcomes assessment
Their work encompasses both preventive and therapeutic interventions in complex transplant scenarios.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.